By Hugo Francisco de Souza New clinical trial evidence suggests targeting both obesity and sleep-disordered breathing ...

In less than 90 minutes, a new, less invasive electrical stimulation technique has been found to improve breathing in people with sleep apnea. The technique, which involves percutaneous hypoglossal ...

The Food and Drug Administration has approved Zepbound, a GLP-1 weight-loss drug from Eli Lilly & Co., for the treatment of moderate to severe sleep apnea certain patients with obesity. Photo courtesy ...

Sleep-disordered breathing (SDB), ranging from habitual snoring to severe obstructive sleep apnea (OSA), is highly prevalent ...

The Food and Drug Administration (FDA) has approved Zepbound ® (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity. Zepbound is a dual ...

The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication approved to ...

Please provide your email address to receive an email when new articles are posted on . Individuals with moderate to severe obstructive sleep apnea had increased odds of having neovascular AMD.

Zepbound (tirzepatide) is a brand-name injection prescribed for treating sleep apnea. This article covers topics such as side effects, dosage, and how Zepbound works. Zepbound is available in ...

We're all chasing better rest. From herbal teas and nighttime routines to white noise machines and tracking apps, quality sleep is now a key part of the wellness conversation. But for people with ...

Sleep apnea will become more common and more severe due to global warming, leading to increased health and economic burdens across the globe, warn Flinders University sleep experts. A new study, ...

Over half of newborns with severe spina bifida experience sleep-disordered breathing, an often overlooked early threat to ...